Materials • Major Chemicals
$73.85 ▲ +0.08
(+0.11%)
MKT CAP: $3.81B • VOL: 392.3K
52W L $58 52W H $95
ROARABLE / RQD
B+ • 77/100
PIOTROSKI
7 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$62
MEDIAN
$83
MEAN
$84
HIGH
$100
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CBT TAPE
CBT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $89.36 | $84.93 | 2025-02-14 | $67.20 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $93.05 | $87.14 | 2025-02-06 | $69.42 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $84.19 | $81.23 | 2025-01-29 | $70.90 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $75.33 | — | 2025-01-17 | $72.37 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $64.99 | $70.16 | 2025-01-09 | $65.73 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $87.88 | $76.80 | 2024-12-18 | $64.25 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $71.63 | $74.59 | 2024-12-04 | $68.68 | -4.3% | 48% | C |